The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine
- PMID: 3012941
- DOI: 10.1111/j.1600-0773.1986.tb00093.x
The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine
Abstract
The effect of two closely related xanthine derivatives, pentoxifylline and HWA 285, on cyclic AMP accumulation in rat hippocampal slices and on adenosine uptake in erythrocytes was examined. Pentoxifylline was a weak competitive antagonist of adenosine effects on cyclic AMP accumulation. HWA 285, by contrast, had a small stimulatory effect per se and also potentiated the effect of adenosine (10-30 microM). Neither pentoxifylline nor HWA 285 significantly affected the cyclic AMP accumulation induced by the stable adenosine analogue NECA or by alpha- or beta-adrenoceptor activation. HWA 285 was a much more potent inhibitor of adenosine uptake into human erythrocytes than pentoxifylline and other examined xanthines including thiocaffeine, 8-p-sulphophenyltheophylline, theophylline, caffeine and enprofylline. It is suggested that HWA 285 may potentiate, rather than antagonize, the effects of endogenous as well as exogenous adenosine, partly as a consequence of adenosine uptake inhibition.
Similar articles
-
The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.Acta Pharmacol Toxicol (Copenh). 1984 Jan;54(1):64-71. doi: 10.1111/j.1600-0773.1984.tb01896.x. Acta Pharmacol Toxicol (Copenh). 1984. PMID: 6322517
-
Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices.Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):173-8. doi: 10.1007/BF00511409. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3010142
-
Interaction of pentoxifylline with human erythrocytes. I. Interaction of xanthine derivatives with human erythrocyte ghosts.Chem Pharm Bull (Tokyo). 1990 Feb;38(2):552-4. doi: 10.1248/cpb.38.552. Chem Pharm Bull (Tokyo). 1990. PMID: 2337972
-
Xanthine interference with dipyridamole-thallium-201 myocardial imaging.Ann Pharmacother. 1995 Apr;29(4):425-7. doi: 10.1177/106002809502900414. Ann Pharmacother. 1995. PMID: 7633022 Review.
-
Effects of enprofylline and theophylline may show the role of adenosine.Life Sci. 1986 Mar 24;38(12):1057-72. doi: 10.1016/0024-3205(86)90241-9. Life Sci. 1986. PMID: 3007902 Review.
Cited by
-
Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.Exp Clin Cardiol. 2004 Summer;9(2):103-11. Exp Clin Cardiol. 2004. PMID: 19641695 Free PMC article.
-
Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia.Br J Pharmacol. 1990 Aug;100(4):814-8. doi: 10.1111/j.1476-5381.1990.tb14097.x. Br J Pharmacol. 1990. PMID: 2207501 Free PMC article.
-
Chronic effects of xanthines on levels of central receptors in mice.Cell Mol Neurobiol. 1999 Dec;19(6):719-32. doi: 10.1023/a:1006901005925. Cell Mol Neurobiol. 1999. PMID: 10456233 Free PMC article.
-
Effect of propentofylline on the biochemical lesion of the rat brain in aluminium-induced neurotoxicity.Metab Brain Dis. 1990 Mar;5(1):7-17. doi: 10.1007/BF00996974. Metab Brain Dis. 1990. PMID: 2336050
-
'Therapeutic window's for multiple drug treatment of experimental cerebral ischemia in gerbils.Neurochem Res. 1994 Feb;19(2):189-94. doi: 10.1007/BF00966815. Neurochem Res. 1994. PMID: 7910380
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources